Apollo Hospitals, INE438A01022

Apollo Hospitals Stock - Analyst consensus and strategy backdrop midweek

17.06.2026 - 21:53:59 | ad-hoc-news.de

Apollo Hospitals stock trades near recent highs while investors weigh analyst expectations and the group’s multi-year expansion and digital health strategy. A look at where the consensus stands and how the business model underpins the valuation.

Apollo Hospitals, INE438A01022
Apollo Hospitals, INE438A01022

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 19:53 UTC. Details in the imprint.

Apollo Hospitals (INE438A01022) remains one of India’s most closely watched healthcare names on the National Stock Exchange. Midweek, investors are again looking at consensus expectations and the group’s expansion plans rather than any fresh corporate filing or earnings release.

Go deeper

All news and price data on Apollo Hospitals stock

Background reports, prior releases and real-time prices provide additional context for Apollo Hospitals’ long-running expansion story.

What analysts are signaling

On the sell-side, Apollo Hospitals continues to feature prominently in India healthcare baskets, with several brokers highlighting robust bed additions and tariff support as key earnings drivers over the next few years, according to recent analyst commentary summarized by Moneycontrol.

Market data services point to a strong one-year total return of roughly 19-20% for the stock, underpinned by steady revenue growth and margin improvement in the core hospital business.

Consensus and valuation backdrop

Recent snapshots of Apollo Hospitals’ valuation put the stock on a rich earnings multiple relative to the broader Indian market, reflecting both its market position and expectations for ongoing capacity expansion.

Moneycontrol notes that management has signaled continued capex for new beds and digital initiatives even as sector peers face cost pressures from a weaker rupee and rising imported equipment costs.

How the business is positioned

Apollo Hospitals generates most of its revenue from inpatient and outpatient services at its multi-specialty hospitals network across India, complemented by diagnostics, pharmacies and emerging digital health offerings.

Industry coverage highlights that the group is targeting additional bed capacity over the next few years, aiming to capture demand growth in tier-1 and tier-2 cities amid rising healthcare spending.

The product behind the stock

At the center of the business is the Apollo branded network of tertiary-care hospitals, which offers specialties ranging from cardiology and oncology to orthopedics and organ transplants, supported by diagnostics and pharmacy services across the group’s footprint.

Where the stock trades today

As of 06/17/2026, 19:30 IST, Apollo Hospitals shares trade on the National Stock Exchange of India at around INR 8,465.

Key facts on Apollo Hospitals stock

  • Company: Apollo Hospitals Enterprise Ltd
  • ISIN: INE438A01022
  • WKN: 919854
  • Ticker: APOLLOHOSP
  • Venue: NSE
  • Price (as of 06/17/2026, 19:30 IST): 8,465.00 INR
  • Market cap: 1,22,000.00 crore INR (as of 06/17/2026)
  • Sector / Industry: Healthcare - Hospital & Healthcare Services
  • Index membership: Nifty 50
  • Next earnings date: not officially scheduled

More on Apollo Hospitals stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | INE438A01022 | APOLLO HOSPITALS | boerse | 69566487 | bgmi